Stay updated on Emactuzumab and Atezolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.

Latest updates to the Emactuzumab and Atezolizumab Combination Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check15 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe page now displays Revision: v3.4.2. The notice about a lapse in government funding and the previous Revision: v3.4.1 reference have been removed.SummaryDifference0.4%

- Check50 days agoChange DetectedA government funding status notice was added to the page and the site revision updated to v3.4.1, with the previous v3.4.0 revision removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedUI and metadata updates include showing the glossary, a standardized QC criterion label ('Last Update Submitted that Met QC Criteria'), and a new Revision: v3.4.0. Older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or replaced.SummaryDifference0.2%

- Check72 days agoChange DetectedThe page revision label changed from v3.3.3 to v3.3.4, a minor technical update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Emactuzumab and Atezolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.